iQure Pharma Inc.IP
SEC Form D filing

iQure Pharma Inc.

Biotech · Series A · Regulation D 506(b) · NJ · Filed June 3, 2026

Offering amount
$4.0M
Exemption
Reg D 506(b)
Issuer state
NJ
Filing date
June 3, 2026
Signature date
June 3, 2026
CIK
0001996977

Summary

Auto-generated

pharmaceutical company, $4M series-a in NJ

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.